Chi Qu

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer.⚑
  2021 L1 51/100 ⚑

1 assessed by us (0 reproduced) · 26 not yet assessed — every PubMed paper on record, linked below.

• 700 Spatial Transcriptome Sequencing-Based Analysis of Efficacy Biomarkers for Predicting the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma ↗

  Laboratory Investigation · 2026
  not yet assessed
• StereoMM: a graph fusion model for integrating spatial transcriptomic data and pathological images ↗

  Briefings in Bioinformatics · 2025 · PMID 40407386
  not yet assessed
• 1347 Boosting Prognosis Analysis of Patients with Diffuse Large B-cell Lymphoma through the Spatial Multi-modal Analysis Framework ↗

  Laboratory Investigation · 2025
  not yet assessed
• StereoSiTE: a framework to spatially and quantitatively profile the cellular neighborhood organized iTME ↗

  GigaScience · 2024 · PMID 39452614
  not yet assessed
• Abstract LB016: Spatial transcriptomics-based platform for pathological diagnosis and research of colorectal cancer ↗

  Cancer Research · 2024
  not yet assessed
• StereoMM: A Graph Fusion Model for Integrating Spatial Transcriptomic Data and Pathological Images ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2024
  not yet assessed
• StereoMM: A Graph Fusion Model for Integrating Spatial Transcriptomic Data and Pathological Images ↗

  Research Square · 2024
  not yet assessed
• Expression of proline-rich protein 15 in breast cancer and its effect on cell biological function ↗

  Macromolecular Research · 2023
  not yet assessed
• Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy ↗

  Annals of Medicine · 2022 · PMID 36194178
  not yet assessed
• Ferroptosis Biology and Implication in Cancers ↗

  Frontiers in Molecular Biosciences · 2022 · PMID 35531466
  not yet assessed
• A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma ↗

  Aging · 2022 · PMID 35085103
  not yet assessed
• Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis-Related Genes in Breast Cancer ↗

  Journal of Oncology · 2022 · PMID 36059802
  not yet assessed
• StereoSiTE: A framework to spatially and quantitatively profile the cellular neighborhood organized iTME ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2022
  not yet assessed
• Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells ↗

  Breast Cancer · 2021 · PMID 33569740
  not yet assessed
• A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma ↗

  Scientific Reports · 2021 · PMID 34475496
  not yet assessed
• JAM2 predicts a good prognosis and inhibits invasion and migration by suppressing EMT pathway in breast cancer ↗

  International Immunopharmacology · 2021 · PMID 34923424
  not yet assessed
• Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer⚑

  Frontiers in Immunology · 2021 · PMID 33986754
  L1 51/100 ⚑
• Organoids from Patient Biopsy Samples can Predict the Response of BC Patients to Neoadjuvant Chemotherapy ↗

  Research Square · 2021
  not yet assessed
• A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma ↗

  Research Square · 2021
  not yet assessed
• A look into the link between centrosome amplification and breast cancer ↗

  Biomedicine & Pharmacotherapy · 2020 · PMID 33128942
  not yet assessed
• A cerium-based fluorescent nanosensor for highly specific detection of glutathione over cysteine and homocysteine ↗

  The Analyst · 2020 · PMID 33140752
  not yet assessed
• Prognostic value of programmed cell death ligand-1 expression in breast cancer ↗

  Medicine · 2020 · PMID 33285715
  not yet assessed
• High expression of JAM2 indicates better prognosis and immunotherapy response in breast cancer ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2020
  not yet assessed
• A Ferroptosis-associated Gene Signature for the Prediction of Prognosis and Therapeutic Response in Luminal-type Breast Carcinoma ↗

  Research Square · 2020
  not yet assessed
• Study characteristics affecting the responses to neoadjuvant chemotherapy and the prognosis of patients with bilateral breast cancer: A retrospective analysis ↗

  2019
  not yet assessed
• Moistening Effect Analyses in Tibet in Recent Several Decades

  Gaoyuan qixiang · 2009
  not yet assessed
• チベット地区における最近数十年間の加湿効果の研究【JST・京大機械翻訳】

  Gaoyuan qixiang · 2009
  not yet assessed